Librella destocking impact
Librella revenue decline will continue to pressure revenue in H1 FY27, with near-zero contribution in Q1 and Q2.
SYNGENEINTERNATIONAL / bear-case history
Track the concerns that keep returning.
Syngene International · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
high
Bay View facility cost drag
Bay View costs are only partially capitalized; full impact on P&L not yet known, potentially pressuring margins.
Geopolitical and tariff risks
Section 232 tariffs on pharma products could slow CDMO order flow, though management assesses negligible impact.
Margin trajectory uncertainty
Management cut margin guidance mid-year but beat it; path to high-20s margins remains unclear.